Effect of Catheter Type on Efficacy of Percutaneous Caudal Adhesolysis

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06051149
Collaborator
(none)
78
3
24

Study Details

Study Description

Brief Summary

The approach toward FBSS involves conservative management that consists of physical therapy and medication which aims to optimize gait and posture and can improve muscle strength and physical function

Condition or Disease Intervention/Treatment Phase
  • Procedure: caudal adhesolysis using RACZ Catheter
  • Procedure: caudal adhesiolysis using NAVI Catheter
N/A

Detailed Description

The international association for the study of pain has defined failed back syndrome as persistent pain despite spine surgery in the same topographical area[1] .

Several causes have been introduced for FBSS including pressure on the nerve root due to disc re-herniation or retained disc fragment, epidural fibrosis, acquired stenosis, and segmental instability.

Thus, FBSS is a syndrome with diverse etiologies and noticeable heterogeneity among patients. However, about 20% to 36% of FBSS occur due to epidural fibrosis, which is a progressive disease[2].

The approach toward FBSS involves conservative management that consists of physical therapy and medication which aims to optimize gait and posture and can improve muscle strength and physical function[3, 4]. Oral pharmacological treatment of FBSS is multimodal and increasingly controversial. Treatments include antiepileptics, non-steroidal anti-inflammatory drugs, oral steroids, antidepressants, and opioids including injections, and finally surgical options as a last line therapy. Other modalities including minimally invasive procedures like epidural injections, Epidural steroid injections (ESIs) are the most commonly performed procedure in pain clinics around the world[5]. These can be administered primarily by three approaches: transforaminal, interlaminar, or caudally, and are indicated for symptoms of radiculopathy. Also radiofrequency ablation of nerves are often used to provide sustained relief that a diagnostic block or therapeutic injection cannot provide. Successfully targeting the intended nerve is achieved, maximizing the size of the lesion. Spinal cord stimulation (SCS) is a nother treatment modality that has shown tremendous potential in the management of FBSS. Adhesions can theoretically be lysed, thereby improving baseline pain scores and drug delivery of the ESI. Lysis of adhesions typically occurs by delivering hyaluronidase with hypertonic saline into the epidural space. The use of hyaluronidase with steroid may be more effective and have longer duration of effect than either one alone. Finally, surgical revision for FBSS is associated with a high morbidity with corresponding low rates of success.

Percutaneous adhesiolysis (PA), is a minimally invasive technique, that might be useful in the treatment of chronic pain refractory to conservative treatments[6]. The basic idea behind PA is inserting a catheter in the ventral epidural space could directly break up perineural/epidural adhesions, that act as physical barriers to the perineurally deposited drugs but also cause neural irritation predisposing to neural inflammation [7].

Study Design

Study Type:
Interventional
Anticipated Enrollment :
78 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
double-blinded, prospective studydouble-blinded, prospective study
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Masking Description:
Will be performed in a sterile operating room under appropriate sterile precautions with help of assistant nurse who will open catheter set before principal investigator enter the operating room and the patient will be blinded.
Primary Purpose:
Treatment
Official Title:
Effect of Catheter Type on Efficacy of Percutaneous Caudal Adhesolysis in Failed Back Surgery Syndrome.
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Jan 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Epidural Catheter

procedure Will be performed under sterile precautions utilizing fluoroscopy, RK needle.patient will be placed prone with a pillow under the abdomen.The sacral area draped from the top of the iliac crest to the bottom of the buttocks.The sacral Corns and the sacral hiatus will be palpated,is in the gluteal fold opposite the affected side will be infiltrated with lidocaine16gauge RK needle will be passed through the described entry point advanced to a point below the S3foramen to prevent S3nerve root damage.Placement will be confirmed by lateral and anteroposterior fluoroscopic views and after aspiration is negative for blood and CSF10mL of iohexol will be injected under fluoroscopy.Once the needle placement is confirmed to be in the epidural space, a lumbar epidurogram will be carried out utilizing approximately2to5 mL of contrast. then the bevel of the needle should face the ventrolateral aspect of the caudal canal.

Procedure: caudal adhesolysis using RACZ Catheter
caudal adhesolysis for patients with failed back surgery syndrome using RACZ Catheter under fluroscopy

Procedure: caudal adhesiolysis using NAVI Catheter
caudal adhesolysis for patients with failed back surgery syndrome using NAVI Catheter under fluroscopy

Active Comparator: RACZ Catheter

same as procedure described above but using RACZ Catheter set

Procedure: caudal adhesolysis using RACZ Catheter
caudal adhesolysis for patients with failed back surgery syndrome using RACZ Catheter under fluroscopy

Active Comparator: NAVI catheter

same as procedure described above but using NAVI Catheter set

Procedure: caudal adhesiolysis using NAVI Catheter
caudal adhesolysis for patients with failed back surgery syndrome using NAVI Catheter under fluroscopy

Outcome Measures

Primary Outcome Measures

  1. pain score [6 months after intervention]

    -difference in numeric rating scale (NRS) at 6 months after intervention

Secondary Outcome Measures

  1. functional outcome [6 months after intervention]

    The Oswestry Disability Index (ODI)

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • previous back surgery of at least 6 months duration, age ≥ 18, failure of conventional pharmacological management, Chronic low back and/or lower extremity pain which failed to respond to fluoroscopically-directed epidural injections with at least 6 weeks post epidural steroid injection, and acceptance to provide a written consent.
Exclusion Criteria:
    • cauda equina syndrome, compressive radiculopathy, uncontrolled major depression or psychiatric disorders, pregnant or lactating women, patients unable to understand the informed consent and protocol, infection, anti-coagulant therapy, non-aspirin anti-platelet therapy.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mostafa Abul-Fotouh Mohamed, doctor, Assiut University
ClinicalTrials.gov Identifier:
NCT06051149
Other Study ID Numbers:
  • AUN1615
First Posted:
Sep 22, 2023
Last Update Posted:
Sep 22, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mostafa Abul-Fotouh Mohamed, doctor, Assiut University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2023